Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

Marquette University

Marquette University, with a generous grant from the Templeton Religion Trust, is pleased to announce a new research initiative on the topics of the self, motivation, and virtue. Approximately ten research proposals at $190,000 each will be funded through this initiative.

The grant competition has four primary aims:
1. To support innovative research on the self, motivation, and virtue.
2. To encourage methodological innovation in the study of the self, motivation, and virtue.
3. To encourage interdisciplinary team work, specifically between social science and humanities.
4. To support scholars new to the investigation of these topics or who have not received funding elsewhere. Research collaborations between younger and more established scholars are especially encouraged.

Research into character and virtue is often conducted by scholars from within a single disciplinary perspective. This disciplinary isolationism is not maximally productive of new knowledge about virtue. To ensure that research funded by this proposal closes the disciplinary gap, successful teams will be comprised of at least one humanist and one scientist who are fully and equally invested in the research project, from its inception to its completion. The aim here is to encourage awardees to think outside of their own disciplinary perspectives, and to broaden their research horizons in ways conducive to creative collaborations and results.

For more information on this extended deadline, please visit the Marquette University website or contact Marquette at: smvproject@marquette.edu.

 
Division of Infectious Diseases & HIV Medicine, CWRU and UH Case Medical Center

Announcement of Infectious Diseases Research Support from STERIS Corporation
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Case Medical Center, with funds from STERIS Corporation, will provide seed money to faculty to foster research in emerging and healthcare-associated infections.

Announcement of Infectious Diseases Research Support from the Infectious Diseases & Immunology Institute (IDII)
The Infectious Diseases & Immunology Institute (IDII) at Case Western Reserve University will provide seed money to young investigators (within 5 years of appointment) to foster interdisciplinary research in infectious diseases and immunology.

For more information on these opportunities, please contact Martha Salata at 844-1988 or mks18@case.edu or visit the Center’s website.

 
National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH)

The NIH Office of Research on Women's Health (ORWH) and participating NIH components, including the National Institute on Drug Abuse, invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs." Programs will support mentored research career development of junior faculty members, known as BIRCWH Scholars, who have recently completed clinical training or postdoctoral fellowships, and who will be engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services research relevant to women's health, and where appropriate the use of both sexes to better understand the influence of sex as a variable on health and disease.

A letter of intent is due December 5 and applications are due January 5, 2015, by 5:00 PM local time of applicant organization.

For more information on this funding opportunity, visit the NIH website.

 
NEW Limited Submission: NIH Director’s Early Independence Award

Key Deadlines: December 1, 2014, 5:00pm (CWRU Letter of Intent), December 30, 2014, 5:00pm EST (agency Letter of Intent), January 30, 2015, 5:00pm EST (agency application).

The NIH Director's Early Independence Awards provide an opportunity for exceptional junior scientists to accelerate their entry into an independent research career by forgoing the traditional post-doctoral training period. Though most newly graduated doctoral-level researchers would benefit by post-doctoral training, a small number of outstanding junior investigators would benefit instead by launching directly into an independent research career. For these select investigators, who have established a record of scientific innovation and research productivity and who have demonstrated unusual leadership, drive, and maturity, post-doctoral training would unnecessarily delay their entry into performing independent research. The NIH Director's Early Independence Awards also provide an opportunity for institutions to invigorate their research programs by bringing in the fresh perspectives of the awardees that they host.

Number of Applications Allowed: Two candidates as determined by the institution.
Amount of Funding: $250,000 per year, in direct costs, for a five-year period

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
The Cleveland Area Reliant IRB Review Process

The Cleveland Area Reliant Institutional Review Board (IRB) Review process includes participation by the Case Western Reserve University (CWRU) Social, Behavioral, and Educational Research (SBER) IRB, the Cleveland Clinic (CC) IRB, MetroHealth Medical Center (MHMC) IRB, and University Hospitals Case Medical Center (UHCMC) IRB. The process relies on executed IRB Authorization Agreements (IAA) between the institutions. These agreements document that all applicable human research subjects protection considerations will be made by one Institutional Review Board (IRB), which will be deemed the IRB of record. The IRBs of the other Cleveland area institutions will accept the approval of the IRB of record through the Reliant Review process. The goal is to eliminate duplication of effort and multiple applications for submission of the same protocol, and to encourage scientific collaboration among the affiliated institutions.

What types of studies are eligible for the Reliant Review Process?
Any type of human research study could be eligible for the Reliant Review process. These include but are not limited to investigator-initiated, federally-funded, foundation-supported, industry-sponsored, and non-funded studies.

The fundamental requirement is that a collaborating investigator must be named at each site where the research will occur. It is important for the Principal Investigator at the lead study site to work with the IRB of record throughout the Reliant Review Process to initiate acceptance of IRB approval at each collaborating site.

For further information, contact Kim Volarcik at (216) 368-0134 or kav6@case.edu.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.